Back
Monopar Therapeutics Stock Price Chart
This DeFi Coin Could 10x Soon... I Advise You Get In Now!
Discover this DeFi diamond before the next surge
Buy
63
MNPR
Monopar Therapeutics
Last Price:
0.78
Seasonality Move:
-14.68%
7 Day Trial
ALL ACCESS PASS
$
7
7 Powerhouse Stocks to Buy and Hold Forever
Get it now.- Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and MNPR is experiencing slight buying pressure.
Monopar Therapeutics Price Chart Indicators
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 0.67 | Buy |
| 20-day SMA: | 0.68 | Buy |
| 50-day SMA: | 0.76 | Buy |
| 200-day SMA: | 0.56 | Buy |
| 8-day EMA: | 0.69 | Buy |
| 20-day EMA: | 0.68 | Buy |
| 50-day EMA: | 0.67 | Buy |
| 200-day EMA: | 0.75 | Buy |
Monopar Therapeutics Technical Analysis Indicators
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0 | Sell |
| Relative Strength Index (14 RSI): | 59.05 | Buy |
| Chaikin Money Flow: | 7745 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (0.62 - 0.72) | Buy |
| Bollinger Bands (100): | (0.35 - 0.81) | Buy |
Monopar Therapeutics Technical Analysis
| Apr 23 | Apr 24 | Apr 25 | Apr 26 | Apr 29 | Apr 30 | May 1 | May 2 | May 3 | May 6 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Apr | May | |||||||||
| 23 | 24 | 25 | 26 | 29 | 30 | 01 | 02 | 03 | 06 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Technical Analysis for Monopar Therapeutics Stock
Is Monopar Therapeutics Stock a Buy?
- Monopar Therapeutics share price is 0.76 while MNPR 8-day simple moving average is 0.67, which is a Buy signal.
- The stock price of MNPR is 0.76 while Monopar Therapeutics 20-day SMA is 0.68, which makes it a Buy.
- Monopar Therapeutics 50-day simple moving average is 0.76 while MNPR share price is 0.76, making it a Buy technically.
- MNPR stock price is 0.76 and Monopar Therapeutics 200-day simple moving average is 0.56, creating a Buy signal.
MNPR Technical Analysis vs Fundamental Analysis
Buy
63
Monopar Therapeutics (MNPR)
is a Buy
Is Monopar Therapeutics a Buy or a Sell?
-
Monopar Therapeutics stock is rated a Buy
The current Monopar Therapeutics [MNPR] share price is $0.76. The Score for MNPR is 63, which is 26% above its historic median score of 50, and infers lower risk than normal.
Monopar Therapeutics Stock Info
Market Cap:
13.22M
Price in USD:
0.76
Share Volume:
81.02K
Monopar Therapeutics 52-Week Range
52-Week High:
1.75
52-Week Low:
0.27
Buy
63
Monopar Therapeutics (MNPR)
is a Buy
Monopar Therapeutics Share Price Forecast
-
What is the Monopar Therapeutics stock price today?
The Monopar Therapeutics stock price is 0.76 USD today. -
Will MNPR stock go up or go down?
Monopar Therapeutics> share price is forecast to RISE/FALL based on technical indicators -
Is Monopar Therapeutics overvalued?
According to simple moving average, exponential moving average, oscillators, and other technical indicators, Monopar Therapeutics is not overvalued.
Is Monopar Therapeutics Stock a Buy?
- Monopar Therapeutics share price is 0.76 while MNPR 8-day exponential moving average is 0.69, which is a Buy signal.
- The stock price of MNPR is 0.76 while Monopar Therapeutics 20-day EMA is 0.68, which makes it a Buy.
- Monopar Therapeutics 50-day exponential moving average is 0.67 while MNPR share price is 0.76, making it a Buy technically.
- MNPR stock price is 0.76 and Monopar Therapeutics 200-day simple moving average is 0.75, creating a Buy signal.
Fundamental Analysis of Monopar Therapeutics
Is Monopar Therapeutics a good investment?
- Analysts estimate an earnings decrease this quarter of $0.03 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.07 per share, and an increase next year of $0.12 per share.
Technical Analysis of Monopar Therapeutics
Should I short Monopar Therapeutics stock?
- MNPR Moving Average Covergence Divergence (MACD) indicator is -0, suggesting Monopar Therapeutics is a Sell
- Monopar Therapeutics Relative Strength Index (RSI) is 59.05, which suggest Monopar Therapeutics is overbought
- The Bollinger Bands (25) for Monopar Therapeutics is (0.62 - 0.72), which suggest Monopar Therapeutics is a Buy
- The Bollinger Bands (100) for Monopar Therapeutics is (0.35 - 0.81), which suggest Monopar Therapeutics is a Buy
* Monopar Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.